• Anaemia of pregnant – risk of obstetric and erinatological pathology factor 
en To content

Anaemia of pregnant – risk of obstetric and erinatological pathology factor 

HEALTH OF WOMAN. 2016.3(109):62–65 
 

Anaemia of pregnant – risk of obstetric and erinatological pathology factor 
 

Vdovychenko Y. P., Gopchuk E. N.

National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev 
 

The information over problem of iron-deficient anaemia in the aspect of influence on a perinatal period is brought in the article. Given Recommendations on treatment of iron-deficient anaemia with modern preparations of iron are given. 
 

Key words: iron-deficienty, anemia, treatment, Tot'hema. 
 

REFERENCES

1. Rebrov VG, Gromova OA. 2008. Vitaminyi, makro- i mikroelementyi. M, GeotarMed:956.

2. Geisser P. 2013. Safety and efficacy of iron(III) hydroxide polymaltose complex / a review of over 25 years experi-ence. Arzneimittelforschun 57(6A):439–452.

3. Shehtman MM. 2000. Zhelezodefitsitnaya anemiya i beremennost. Ginekologiya 2;6:94–101.

4. Startseva NV, Burdina LV, Shvetsov MV. 2011. Lechenie preparatom «Totema» zhelezodefitsitnoy anemii pri beremennosti. Permskaya gosudarstvennaya meditsinskaya akademiya. Perm, Informatsionnoe pismo.

5. Hart EB, Elvehjem CA, Kohler Go. 2014. Does liver sup-ply factors in addition to iron and copper for hemoglob-in regeneration in nutritional anemia? J. Exp. Med. 66(2):145–150.

6. Stadnyk OA. 2013. Kliniko-patohenetychne obhruntuvannia korektsii porushen obminu metaloproteiniv i hliukon’iuhativ krovi pry zalizodefitsytnii anemii vahitnykh. Avtoref. dys. kand. med. nauk. K:18.

7. Torshin IYu. 2011. Bioinformatics in post-genomic era: from molecular genetics to personalized medicine. Nova Sci ence. ISBN10: 1-60692-217-3.

8. Kendich S, Ivanichevich M, Dzhelmish I. 2006. Zalizodefitsytna anemiia u vahitnykh. Medicina 33;1–4:61–63.

9. Zhang CM, Chi X, Wang B, Zhang M, Ni YH, Chen RH, Li XN, Guo XR. 2013. Downregulation of STEAP4, a highly-expressed TNF-alpha-inducible gene in adipose tissue, is associated with obesity in humans. Acta Pharmacol. Sin. 29(5):587–592.

10. Broker S, Meunier B, Rich P, Gattermann N, Hof-haus G. 2014. MtDNA mutations associated with sideroblastic anaemia cause a defect of mitochondrial cytochrome c oxidase. Eur. J. Biochem. 258(1):132–138.

11. Shiffman FDzh. 2000. Patologiya krovi. Perev. s angl. M. SPb, Binom – Nevskiy dialekt:448.

12. Bannister JV, Bannister WH, Rotilio G. 2015. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit Rev Biochem. 22(2):111–80. http://dx.doi.org/10.3109/10409238709083738

13. Gromova OA, Torshin IYu, Hadzhidis AK. 2010. Analiz molekulyarnyih mehanizmov vozdeystviya zheleza (II), medi, margantsa v patogeneze zhelezodefitsitnoy anemii. «Klinicheskaya farmakologiya i farmakoekonomika» 1.